Search clinical trials for: S-1, capecitabine

Total 17415 results

Samsung Medical Center
National Cancer Center, Korea; Asan Medical Center; Chonnam National University... and other collaborators

Completed

Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer

Colorectal Cancer

Korea, Republic of
National Cancer Center, Korea

Unknown

S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer

Stomach Neoplasms

Korea, Republic of
The First Affiliated Hospital of Zhengzhou University

Recruiting

Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage

Gastric Cancer

China
Seoul National University Hospital
Korean Cancer Study Group; Ministry of Health & Welfare, Korea

Completed

Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer

Gastric Cancer

Korea, Republic of
Peking University
Taiho Pharmaceutical Co., Ltd.

Unknown

Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection

Advanced Gastric Carcinoma

China
Hallym University Medical Center
Sanofi

Completed

Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer

Colorectal Neoplasm

Korea, Republic of
Japan Breast Cancer Research Network

Completed

Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer

Breast Neoplasms

Japan
Tomoshi Tsuchiya

Completed

A Feasibility Study of Oral Adjuvant Chemotherapy With S-1

Non-small Cell Lung Cancer

Japan
Asan Medical Center

Completed

Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial

Gastric Cancer

Korea, Republic of
Fudan University
The First Affiliated Hospital of Anhui Medical University; Guangdong Provincial... and other collaborators

Withdrawn

Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.

Gastric Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer (RESCUE-GC)

Gastric Cancer

China
Sun Yat-sen University

Unknown

Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer (CAPITAL)

Gastric Cancer

China
Fudan University

Recruiting

A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection

Recurrence | Cholangiocarcinoma | Biliary Tract Neoplasms | Gall Bladder Cancer

China
Zhejiang Cancer Hospital

Completed

S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer

Esophageal Cancer

China
Taiho Oncology, Inc.
Quintiles, Inc.; United BioSource, LLC

Completed

Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer
Hamamatsu University

Unknown

Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer

Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Colon Cancer

Japan
Taiho Oncology, Inc.
Quintiles, Inc.; United BioSource, LLC

Completed

Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer

Locally Advanced or Metastatic Pancreatic Cancer
TTY Biopharm
National Taiwan University Hospital; Chang Gung Memorial Hospital; Taipei Veterans... and other collaborators

Terminated

A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan

Pancreatic Cancer | Adjuvant Chemotherapy | Resected Pancreatic Cancer

Taiwan
Fudan University

Completed

S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Seoul National University Bundang Hospital

Unknown

S-1-induced Lacrimal Drainage Obstruction

Gastric Cancer

Korea, Republic of
Japan Clinical Cancer Research Organization
Kitasato University

Completed

Clinical Trial of Chemosensitivity Test

Gastric Cancer

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)

Gastric Cancer

Japan
Fujian Cancer Hospital
Zhejiang Cancer Hospital; Jiangxi Provincial Cancer Hospital

Not yet recruiting

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Lin Chen

Unknown

SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer (RESONANCE)

Gastric Adenocarcinoma

China
Taiho Oncology, Inc.

Completed

A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors

Tumors

United States
Peking Union Medical College Hospital

Recruiting

The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma.

Efficacy and Safty of Camrelizumab Plus S-1 Maintenance After First-line Induction Chemotherapy for GC

China
AIO-Studien-gGmbH
Taiho Pharmaceutical Co., Ltd.; Nordic Pharma SAS

Completed

Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction (S-1 adjuvant)

Adenocarcinoma,Stomach | Adenocarcinoma, Esophagogastric Junction

Germany
Sun Yat-sen University

Unknown

Maintenance Treatment With S-1 in Gastric Cancer Patients

Gastric Cancer Stage IV | Cancer of Stomach

China
Kyungpook National University Hospital

Unknown

S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer

Gastric Cancer

Korea, Republic of
Hebei Medical University

Completed

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

Gastric Cancer

China
Fudan University

Terminated

SOX as Salvage Treatment in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Japan Adjuvant Study Group of Pancreatic Cancer
Japan Agency for Medical Research and Development; Pharma Valley Center

Completed

Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer

Pancreatic Cancer

Japan
Fudan University

Completed

Study of S-1 in Combination With Radiotherapy in Esophageal Cancer

Esophageal Squamous Cell Carcinoma

China
Taiho Pharmaceutical Co., Ltd.

Completed

A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Japan
Peking University
Taiho Pharmaceutical Co., Ltd.

Unknown

SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer

Pancreatic Cancer | Biliary Tract Cancer | Periampullary Adenocarcinoma

China
Chinese PLA General Hospital

Recruiting

RC48-ADC Combined With S-1 for First-line Treatment of Advanced Gastroesophageal Adenocarcinoma With Moderate Expression of HER2

Advanced Gastroesophageal Adenocarcinoma

China
Zhejiang Provincial People's Hospital

Withdrawn

S-1 and Radiotherapy for Elderly Esophageal Cancer Patients

Esophageal Cancer | Radiotherapy | S-1

China
Sun Yat-sen University

Completed

Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Cancer.

Esophageal Squamous Cell Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...
The First Affiliated Hospital with Nanjing Medical University; Fujian Cancer... and other collaborators

Completed

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

Chemoradiation | Esophagus Cancer | Radiotherapy; Complications | Esophagogastric Junction Cancer

China
University Hospital, Toulouse

Completed

Combined Deep Brain Stimulation in Parkinson's Disease (SCP-FOG)

Parkinson Disease

France
Cancer Institute and Hospital, Chinese Academy...

Unknown

A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer

Stomach Neoplasms | Radiotherapy, Intensity-Modulated | Chemoradiotherapy, Adjuvant

China
Eli Lilly and Company

Completed

A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer

Stomach Neoplasms

Japan
Taiho Pharmaceutical Co., Ltd.

Completed

Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer

Gastric Cancer

China
Sixth Affiliated Hospital, Sun Yat-sen University
Sun Yat-sen University

Recruiting

S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma

Chemotherapy Effect | Locally Advanced Gastroesophageal Junction Adenocarcinoma

China
Asan Medical Center

Completed

S-1 and Photodynamic Therapy in Cholangiocarcinoma

Cholangiocarcinoma

Korea, Republic of
Mianyang Central Hospital

Unknown

S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Chinese PLA General Hospital

Unknown

Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

Gastric Cancer

China
AstraZeneca

Completed

Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients

Gastric Cancer

Japan
Heikki Joensuu

Terminated

Effects of S-1 and Capecitabine on Coronary Artery Blood Flow (FluoHeart)

Stomach Cancer | Small Bowel Cancer | Colon Cancer | Esophagus Cancer | Rectum Cancer

Finland
Shanghai East Hospital

Not yet recruiting

Circulating Tumor DNA Guided Adjuvant Chemotherapy for Biliary Tract Carcinoma

Biliary Tract Cancer

China

Search clinical trials for: S-1, capecitabine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations